Fieldview Capital Management LLC Grows Stake in Encompass Health Corporation $EHC

Fieldview Capital Management LLC boosted its stake in shares of Encompass Health Corporation (NYSE:EHC) by 32.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 35,897 shares of the company’s stock after acquiring an additional 8,871 shares during the quarter. Encompass Health comprises about 0.7% of Fieldview Capital Management LLC’s investment portfolio, making the stock its 28th biggest position. Fieldview Capital Management LLC’s holdings in Encompass Health were worth $4,560,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of EHC. Tectonic Advisors LLC increased its position in shares of Encompass Health by 1.6% during the 3rd quarter. Tectonic Advisors LLC now owns 5,337 shares of the company’s stock valued at $678,000 after purchasing an additional 82 shares during the last quarter. Global Retirement Partners LLC lifted its position in Encompass Health by 23.0% in the third quarter. Global Retirement Partners LLC now owns 449 shares of the company’s stock worth $57,000 after buying an additional 84 shares during the last quarter. EP Wealth Advisors LLC boosted its stake in Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock worth $453,000 after buying an additional 88 shares during the period. Natural Investments LLC increased its position in Encompass Health by 1.2% during the third quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after acquiring an additional 89 shares during the last quarter. Finally, TD Private Client Wealth LLC increased its position in Encompass Health by 1.1% during the third quarter. TD Private Client Wealth LLC now owns 8,216 shares of the company’s stock valued at $1,044,000 after acquiring an additional 91 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Activity

In related news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total value of $16,746,000.00. Following the completion of the sale, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.00% of the company’s stock.

Analysts Set New Price Targets

EHC has been the subject of several analyst reports. Barclays raised their target price on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Zacks Research downgraded shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average target price of $143.29.

Encompass Health Stock Down 0.7%

Shares of EHC opened at $106.89 on Monday. The firm has a fifty day moving average price of $103.93 and a 200-day moving average price of $113.58. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $10.63 billion, a P/E ratio of 19.29, a P/E/G ratio of 2.05 and a beta of 0.71. Encompass Health Corporation has a 12-month low of $92.53 and a 12-month high of $127.99.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter last year, the firm posted $1.17 EPS. The firm’s revenue was up 9.9% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Equities research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, April 1st. Encompass Health’s payout ratio is currently 13.72%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.